Evidence & concentration worksheet · Healing & Recovery
KLOW 80 mg
Human efficacy and a validated dose have not been established for this compound. The former regimen has been withheld; only concentration arithmetic remains available.
Evidence review
No established human dosing protocol
Human efficacy and a validated dose have not been established for this compound. The former regimen has been withheld; only concentration arithmetic remains available.
How it works
KLOW is a seller-defined blend usually described as KPV, BPC-157, TB-500, and GHK-Cu. The name does not guarantee a fixed ingredient identity, ratio, strength, or manufacturing standard, and no FDA-approved KLOW product exists.
Benefits & side effects
No controlled human trial has tested KLOW as a finished formulation. Studies of an individual component, a related full-length protein, a topical route, or an animal model cannot establish benefit for a four-component injectable blend. Claims of faster healing, reduced inflammation, recovery, or “synergy” are unverified.
Calculator
Concentration and measurement calculator
Use this only to check arithmetic from an authoritative product label, registered study protocol, or qualified clinician.
Arithmetic only — not a dose recommendation
Enter only a concentration and target supplied by an authoritative product label, a registered study protocol, or a qualified clinician. A correct conversion does not establish that a substance, vial, route, or dose is safe or effective.
Enter only a concentration and target supplied by an authoritative product label, a registered study protocol, or a qualified clinician. A correct conversion does not establish that a substance, vial, route, or dose is safe or effective.
Source concentration
Source-supplied target
References
References
- U.S. FDA — Certain bulk substances that may present significant compounding safety risks (2026)
- U.S. FDA — July 2026 Pharmacy Compounding Advisory Committee meeting (2026)